Melatonin is an indoleamine hormone secreted primarily by pinealocytes of the pineal gland. Its secretion increases during darkness and conveys information about the environmental light-dark cycle to the body, helping regulate circadian rhythms, sleep timing, and seasonal physiological responses.
Melatonin is an indoleamine hormone produced primarily by pinealocytes of the pineal gland. Its secretion follows a pronounced daily rhythm, with concentrations generally increasing during darkness and remaining relatively low during daylight.
Rather than functioning primarily as a conventional metabolic hormone, melatonin acts as an important signal of environmental darkness. Its rhythmic secretion communicates information about the light-dark cycle to tissues throughout the body and contributes to synchronization of circadian physiology.
Melatonin production is closely connected to the suprachiasmatic nucleus (SCN) of the hypothalamus, the principal circadian pacemaker. Light detected by specialized retinal cells reaches the SCN, which influences the pineal gland through a multisynaptic autonomic pathway. Darkness ultimately increases sympathetic stimulation of pinealocytes and promotes melatonin synthesis, while light suppresses this process.
Melatonin is an indoleamine derived from the amino acid tryptophan.
Its chemical structure and synthesis distinguish it from peptide hormones such as insulin and steroid hormones such as cortisol.
The principal endocrine source of circulating melatonin is the pineal gland.
The pineal gland is a small neuroendocrine structure associated with the epithalamus and located near the roof of the third ventricle.
The pineal gland, or pineal body, projects posteriorly from the region of the diencephalon and is closely associated with the posterior part of the third ventricle.
Its endocrine function is dominated by the synthesis and secretion of melatonin.
Pinealocytes are the principal hormone-producing cells of the pineal gland.
They possess the enzymatic machinery required to convert tryptophan-derived serotonin into melatonin and receive sympathetic neural signals that regulate this pathway according to environmental lighting conditions.
Pineal tissue consists primarily of pinealocytes together with supporting glial cells, connective tissue, blood vessels, and nerve fibers.
The gland is highly vascular, facilitating release of melatonin into the circulation.
The pineal gland commonly contains calcified concretions called corpora arenacea, also known as brain sand.
These deposits generally become more prominent with age and can make the pineal gland visible on radiographic imaging.
Melatonin is synthesized from the amino acid tryptophan through a series of enzymatic reactions involving serotonin as an important intermediate.
The rate of melatonin synthesis varies dramatically according to the light-dark cycle.
Tryptophan is first converted to 5-hydroxytryptophan and subsequently to serotonin.
Serotonin serves as the immediate biochemical precursor for the final stages of melatonin synthesis within pinealocytes.
Serotonin undergoes acetylation to form N-acetylserotonin, which is then methylated to produce melatonin.
The acetylation step is strongly regulated by circadian and sympathetic signals and is an important control point in pineal melatonin production.
| Stage | Product |
|---|---|
| 1 | Tryptophan |
| 2 | 5-Hydroxytryptophan |
| 3 | Serotonin |
| 4 | N-Acetylserotonin |
| 5 | Melatonin |
Aralkylamine N-acetyltransferase (AANAT) catalyzes conversion of serotonin to N-acetylserotonin.
AANAT activity is strongly influenced by circadian and sympathetic regulation and represents a major regulatory point controlling the daily rhythm of melatonin synthesis.
Acetylserotonin O-methyltransferase (ASMT), historically called hydroxyindole-O-methyltransferase, catalyzes conversion of N-acetylserotonin to melatonin.
This reaction represents the final enzymatic step in melatonin synthesis.
The most important environmental regulator of melatonin secretion is the light-dark cycle.
Melatonin secretion generally increases after the onset of darkness, remains elevated during the biological night, and decreases toward morning.
Exposure to light during the biological night can suppress pineal melatonin production.
The magnitude of this effect depends on factors including light intensity, wavelength, duration, timing, and the individual's physiological state.
Darkness removes the light-mediated suppression of the neural pathway controlling the pineal gland.
This permits increased sympathetic signaling to pinealocytes and stimulates melatonin synthesis and secretion.
Environmental light is detected by the retina. Circadian photoreception depends importantly on intrinsically photosensitive retinal ganglion cells containing the photopigment melanopsin.
These cells provide information about environmental illumination to the central circadian system.
Intrinsically photosensitive retinal ganglion cells respond directly to light through melanopsin and also receive input from rods and cones.
Their axons contribute to the retinohypothalamic tract that carries photic information to the suprachiasmatic nucleus.
The retinohypothalamic tract carries information about environmental light from the retina to the hypothalamic circadian system.
Its major circadian target is the suprachiasmatic nucleus.
The suprachiasmatic nucleus (SCN) is located in the anterior hypothalamus immediately superior to the optic chiasm.
It functions as the principal central circadian pacemaker and coordinates daily rhythms in physiology and behavior.
The SCN does not directly innervate pinealocytes. Instead, circadian signals reach the pineal gland through a multisynaptic pathway involving hypothalamic, spinal, and sympathetic structures.
This arrangement allows environmental light information received by the SCN to regulate pineal melatonin production.
| Step | Structure |
|---|---|
| 1 | Retina |
| 2 | Retinohypothalamic tract |
| 3 | Suprachiasmatic nucleus |
| 4 | Hypothalamic autonomic pathways, including the paraventricular region |
| 5 | Preganglionic sympathetic neurons in the upper thoracic spinal cord |
| 6 | Superior cervical ganglion |
| 7 | Postganglionic sympathetic fibers to the pineal gland |
The superior cervical ganglion is an important sympathetic relay in the pathway controlling pineal melatonin secretion.
Postganglionic sympathetic fibers arising from this ganglion innervate the pineal gland.
Unlike many endocrine glands in which sympathetic activation accompanies stress responses, sympathetic activity in the pineal pathway is strongly associated with the environmental dark phase.
During darkness, sympathetic nerve terminals release norepinephrine onto pinealocytes.
Norepinephrine is the major neurotransmitter through which sympathetic fibers stimulate pineal melatonin synthesis.
Norepinephrine acts on adrenergic receptors on pinealocytes and activates intracellular signaling that increases the activity and expression of melatonin-synthetic enzymes.
Beta-adrenergic signaling is particularly important in the nocturnal stimulation of pineal melatonin synthesis, with alpha-adrenergic mechanisms contributing to the response.
Activation of these receptors increases intracellular signaling that promotes AANAT activity.
| Event | Result |
|---|---|
| Environmental darkness | Reduced retinal light signaling |
| Circadian neural output | Permits increased sympathetic drive to the pineal gland |
| Superior cervical ganglion | Provides postganglionic sympathetic input |
| Norepinephrine release | Stimulates pinealocytes |
| AANAT activity | Increases melatonin synthesis |
| Melatonin secretion | Signals biological night to the body |
A circadian rhythm is an approximately 24-hour biological rhythm generated by endogenous timing mechanisms and synchronized to environmental cues.
Melatonin is one of the most recognizable hormonal outputs associated with the circadian system.
The duration and timing of melatonin secretion provide information about the environmental night.
For this reason, melatonin is often described as an endocrine signal of darkness rather than simply as a sleep-producing hormone.
| Period | Typical Melatonin Pattern |
|---|---|
| Daylight | Low |
| Evening darkness | Begins to increase |
| Biological night | Elevated |
| Late night to morning | Declines |
| Daytime | Returns to low concentrations |
Dim light melatonin onset (DLMO) refers to the evening rise in melatonin measured under controlled dim-light conditions.
It is widely used as a physiological marker of circadian phase because the timing of melatonin secretion closely reflects the state of the central circadian clock.
Melatonin contributes to regulation of sleep timing and facilitates physiological conditions associated with nighttime sleep.
Its effects depend strongly on timing. Melatonin should therefore be understood as part of the circadian timing system rather than simply as a general sedative signal.
The sleep-wake cycle is regulated through interactions between circadian timing and homeostatic sleep pressure.
Melatonin provides a hormonal signal associated with circadian night, while increasing sleep pressure during prolonged wakefulness represents a separate regulatory mechanism.
The nocturnal increase in melatonin is associated with physiological changes that accompany preparation for sleep, including changes in thermoregulation.
Melatonin can promote peripheral heat loss and contribute to the decline in core body temperature associated with biological night.
The principal high-affinity melatonin receptors are MT1 and MT2.
Both are G protein-coupled receptors and are expressed in the central nervous system as well as several peripheral tissues.
The MT1 receptor participates in several physiological responses to melatonin, including actions within the circadian system.
Activation of MT1 receptors can influence neuronal activity and cellular signaling associated with nighttime physiology.
The MT2 receptor has an important role in circadian phase regulation.
Activation of MT2-mediated pathways can contribute to shifts in the timing of circadian rhythms depending on when melatonin signaling occurs.
| Receptor | Type | Important Functional Association |
|---|---|---|
| MT1 | G protein-coupled receptor | Nighttime and circadian signaling |
| MT2 | G protein-coupled receptor | Circadian phase regulation |
Melatonin receptors are expressed within the suprachiasmatic nucleus.
Consequently, melatonin generated under control of the circadian system can also signal back to the central clock and influence circadian timing.
Melatonin can alter circadian phase when administered or released at particular biological times.
The direction and magnitude of the phase shift depend strongly on timing relative to the individual's internal circadian rhythm.
Light is the dominant environmental synchronizer of the human circadian system, while melatonin provides an internal hormonal signal of darkness.
Both can influence circadian phase, but they act through different pathways and their effects depend on timing.
Because the duration of nighttime melatonin secretion changes with the length of the dark period, melatonin can encode information about photoperiod.
This mechanism has major seasonal physiological effects in many animal species.
Photoperiod refers to the relative duration of daylight and darkness within a 24-hour period.
Changes in photoperiod alter the duration of nocturnal melatonin secretion, allowing organisms to obtain endocrine information about seasonal changes in day length.
Melatonin has strong effects on seasonal reproduction in many species by conveying photoperiodic information to neuroendocrine reproductive systems.
In humans, the relationship between melatonin and reproductive endocrine function is more complex and less dominated by seasonal control.
Melatonin concentrations and secretion patterns change across development.
The precise physiological significance of these changes for human pubertal timing remains complex and should not be interpreted as a simple direct inhibitory relationship.
Melatonin secretion varies with age. Circadian melatonin rhythms develop after birth, become well established during childhood, and can change during adulthood and aging.
Older adults may exhibit lower nighttime melatonin concentrations or alterations in circadian timing, although considerable individual variability exists.
Newborn infants do not immediately display the mature circadian melatonin rhythm characteristic of older children and adults.
Organization of circadian hormonal rhythms develops progressively during early life as central timing mechanisms mature and become synchronized with environmental cycles.
Aging is frequently associated with changes in circadian organization, sleep timing, and melatonin secretion.
These changes vary substantially between individuals and interact with environmental light exposure, health status, medications, and sleep patterns.
Circulating melatonin is metabolized primarily in the liver.
Metabolism produces compounds that are subsequently conjugated and eliminated, predominantly through the urine.
A major urinary metabolite of melatonin is 6-sulfatoxymelatonin.
Measurement of this metabolite can provide an indirect estimate of melatonin production over a defined collection period.
Melatonin can be assessed in blood or saliva, while urinary metabolites can provide integrated information about secretion.
Because melatonin concentrations vary strongly according to circadian time and environmental light, sampling conditions are critical when interpreting measurements.
Artificial light exposure during the evening and night can alter melatonin secretion and circadian timing.
The biological response depends on the intensity, spectrum, timing, and duration of the light exposure.
The circadian system is particularly sensitive to shorter-wavelength visible light because melanopsin-containing retinal ganglion cells contribute strongly to non-image-forming photoreception.
Appropriately timed exposure can therefore suppress melatonin and alter circadian phase.
Jet lag occurs when the internal circadian system is temporarily misaligned with the environmental light-dark cycle after rapid travel across time zones.
Because melatonin can influence circadian phase, appropriately timed melatonin is used in some circumstances to assist adjustment to a new time zone.
Night work and rotating work schedules can produce misalignment between behavioral schedules, environmental light exposure, and endogenous circadian rhythms.
Melatonin secretion may therefore occur at times that conflict with required wakefulness or sleep.
Abnormal alignment between the internal circadian clock and the desired sleep schedule contributes to several circadian rhythm sleep-wake disorders.
Assessment and treatment may involve careful consideration of light exposure, behavioral scheduling, and appropriately timed melatonin or melatonin-receptor agonists.
Exogenous melatonin can reproduce some of the signaling effects of endogenous melatonin.
Its physiological effect depends substantially on dose and timing relative to the individual's circadian phase, which is why its actions cannot be understood solely in terms of inducing sleepiness.
Pharmacological agents that activate melatonin receptors can influence sleep and circadian physiology.
Their actions reflect signaling through MT1, MT2, or related receptor mechanisms depending on the specific drug.
Calcification of the pineal gland is common and generally increases with age.
Because the pineal gland often becomes radiographically visible, its calcification has historically served as an anatomical midline landmark in neuroimaging.
Tumors occurring in the pineal region can affect nearby structures because of the gland's location close to the posterior third ventricle, tectal region, and cerebral aqueduct.
Clinical manifestations of pineal-region masses are therefore often related to local compression and obstruction rather than simply altered melatonin secretion.
Melatonin and cortisol both exhibit prominent circadian rhythms, but their typical daily patterns differ.
| Feature | Melatonin | Cortisol |
|---|---|---|
| Major source | Pineal gland | Adrenal cortex |
| Hormone class | Indoleamine | Steroid |
| Typical major elevation | Biological night | Late biological night and early morning |
| Major regulatory system | SCN-linked sympathetic pathway | Hypothalamic-pituitary-adrenal axis |
| Important role | Signals darkness and contributes to circadian timing | Metabolic and stress-related regulation with circadian organization |
| Feature | Melatonin | Serotonin |
|---|---|---|
| Relationship | Synthesized from serotonin | Precursor of melatonin in pinealocytes |
| Major pineal role | Secreted circadian hormone | Biochemical intermediate |
| Daily pineal relationship | Production increases during darkness | Used as substrate for nocturnal melatonin synthesis |
Melatonin regulation differs from classical hypothalamic-pituitary endocrine axes.
Its secretion is controlled primarily through a neural pathway connecting retinal light detection and the central circadian clock with sympathetic innervation of the pineal gland.
| Anatomical Structure | Role |
|---|---|
| Retina | Detects environmental light |
| Retinohypothalamic tract | Carries photic information toward the circadian system |
| Suprachiasmatic nucleus | Functions as the principal circadian pacemaker |
| Hypothalamic autonomic pathways | Relay circadian output toward sympathetic neurons |
| Upper thoracic spinal cord | Contains relevant preganglionic sympathetic neurons |
| Superior cervical ganglion | Provides sympathetic relay |
| Pineal gland | Produces melatonin |
| Pinealocytes | Synthesize and secrete melatonin |
| Circulation | Distributes the hormonal darkness signal |
| Feature | Key Point |
|---|---|
| Hormone class | Indoleamine |
| Primary endocrine source | Pineal gland |
| Secretory cell | Pinealocyte |
| Initial precursor | Tryptophan |
| Immediate biochemical precursor | Serotonin |
| Important regulatory enzyme | AANAT |
| Final synthetic enzyme | ASMT |
| Major environmental regulator | Light-dark cycle |
| Central circadian regulator | Suprachiasmatic nucleus |
| Peripheral neural pathway | Sympathetic fibers through the superior cervical ganglion |
| Major pineal neurotransmitter | Norepinephrine |
| Major receptors | MT1 and MT2 |
| Typical secretion | Higher during biological night |
| Major physiological significance | Signals darkness and contributes to circadian and sleep timing |
Melatonin provides one of the clearest examples of integration between the sensory, nervous, autonomic, and endocrine systems. Its production begins with environmental light detection by the retina rather than with a conventional circulating endocrine stimulus.
Specialized retinal ganglion cells transmit information about environmental illumination through the retinohypothalamic tract to the suprachiasmatic nucleus. The SCN uses this information to synchronize its endogenous circadian rhythm with the external day-night cycle.
Circadian output from the hypothalamus reaches the pineal gland through a multisynaptic autonomic pathway involving the spinal cord and superior cervical ganglion. During darkness, sympathetic fibers release norepinephrine onto pinealocytes, increasing the enzymatic activity required for melatonin synthesis.
Melatonin then enters the circulation and communicates information about biological night to tissues throughout the body. Through MT1 and MT2 receptors, it participates in circadian organization, sleep timing, thermoregulation, and other physiological processes.
This organization means that the pineal gland is functionally connected to structures extending from the retina to the hypothalamus, spinal cord, sympathetic chain, and peripheral tissues. Disruption at the level of environmental light exposure, circadian timing, autonomic signaling, or pineal function can therefore alter the normal rhythm of melatonin secretion.
Through its synthesis by pinealocytes, regulation by the retina-SCN-sympathetic pathway, nocturnal secretion, and actions through melatonin receptors, melatonin functions as a major endocrine signal linking the external light-dark environment with the internal temporal organization of human physiology.